Evaluating health related quality of life in outpatients receiving anti-cancer treatment: results from an observational, cross-sectional study
| Autor: | Víctor Sacristán Santos, Lucía Vilanova-Trillo, Hae-Jin Suh Oh, Manuel Constenla Figueiras, Francisca Fernández Ribeiro, Manuel Pereiro Ferreirós, Ángeles Rodríguez Martinez, Ángeles Flórez Menéndez |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Quality of life
medicine.medical_specialty Multivariate analysis Cross-sectional study Computer applications to medicine. Medical informatics R858-859.7 FACT-G Targeted therapies Internal medicine Cutaneous adverse events Neoplasms Outpatients Medicine Humans Adverse effect Cancer Health related quality of life Patient-reported outcomes Performance status business.industry Research Public Health Environmental and Occupational Health General Medicine medicine.disease humanities Cross-Sectional Studies Mental Health Observational study Female business |
| Zdroj: | Health and Quality of Life Outcomes Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-8 (2021) |
| ISSN: | 1477-7525 |
| Popis: | Background The aim of the study was to assess health-related quality of life (HRQOL) in outpatients receiving anti-cancer treatment. Methods Observational, cross-sectional, single-center study that assessed HRQOL in cancer patients receiving antineoplastic treatment. Results A total of 184 patients were included in the study; the median total FACT-G score was 66 ± 12.9; the scores for the physical well-being, social/family well-being, emotional well-being and functional well-being domains were 17.8 + 4.8, 19.1 ± 4.4, 14.8 ± 3.8 and 14.3 ± 4.7 respectively. Patients with adverse events had poorer HRQOL compared to those without them (FACT-G score 62.2 vs. 67.3; p Conclusion In our study, the neoplastic disease and anti-cancer treatment toxicities had an impact on HRQOL. Patients had poorer scores in the functional well-being domain and higher ones in the social/family well-being domain. Variables associated with worse HRQOL were tumor stage, performance status (ECOG) and female sex. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink